Algorae Pharmaceuticals Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.327x

Algorae Pharmaceuticals Ltd cash flow conversion efficiency. Based on the latest financial reports, Algorae Pharmaceuticals Ltd (1AI) has a cash flow conversion efficiency ratio of -0.327x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-618.21K ≈ $-437.42K USD) by net assets (AU$1.89 Million ≈ $1.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Algorae Pharmaceuticals Ltd (2004–2025)

Cash flow conversion efficiency of Algorae Pharmaceuticals Ltd from 2004 to 2025. This chart illustrates how Algorae Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Algorae Pharmaceuticals Ltd for real-time trading data and today's change.

Algorae Pharmaceuticals Ltd Cash Flow Conversion Ratio Explained

Algorae Pharmaceuticals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Algorae Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Algorae Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Also see market value of Algorae Pharmaceuticals Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Inno Holdings Inc. Common Stock NASDAQ:INHD	-0.063x
Tae Won Mulsan KO:001420	0.012x
Grupo Televisa SAB DRC BA:TV	0.054x
Seker Finansal Kiralama AS IS:SEKFK	-0.039x
Ralco Corporation Bhd KLSE:7498	0.037x
Emova Group SA PA:ALEMV	0.190x
GreenPro Capital Corp NASDAQ:GRNQ	-0.061x
Biocardia Inc NASDAQ:BCDA	-0.643x

Annual Cash Flow Conversion Efficiency for Algorae Pharmaceuticals Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Algorae Pharmaceuticals Ltd from 2004 to 2025. Review 1AI free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$2.23 Million ≈ $1.58 Million	AU$-785.25K ≈ $-555.61K	-0.352x	-22.91%
2024-06-30	AU$5.31 Million ≈ $3.76 Million	AU$-1.52 Million ≈ $-1.08 Million	-0.287x	+16.52%
2023-06-30	AU$5.78 Million ≈ $4.09 Million	AU$-1.99 Million ≈ $-1.41 Million	-0.343x	+32.16%
2022-06-30	AU$4.03 Million ≈ $2.85 Million	AU$-2.04 Million ≈ $-1.44 Million	-0.506x	+52.31%
2021-06-30	AU$1.38 Million ≈ $974.40K	AU$-1.46 Million ≈ $-1.03 Million	-1.061x	+1.77%
2020-06-30	AU$2.88 Million ≈ $2.04 Million	AU$-3.11 Million ≈ $-2.20 Million	-1.080x	-124.63%
2019-06-30	AU$4.14 Million ≈ $2.93 Million	AU$-1.99 Million ≈ $-1.41 Million	-0.481x	+3.88%
2018-06-30	AU$7.14 Million ≈ $5.05 Million	AU$-3.57 Million ≈ $-2.53 Million	-0.500x	-11.63%
2017-06-30	AU$7.52 Million ≈ $5.32 Million	AU$-3.37 Million ≈ $-2.38 Million	-0.448x	+19.40%
2016-06-30	AU$5.68 Million ≈ $4.02 Million	AU$-3.16 Million ≈ $-2.23 Million	-0.556x	+20.52%
2015-06-30	AU$5.13 Million ≈ $3.63 Million	AU$-3.59 Million ≈ $-2.54 Million	-0.700x	-7056.25%
2014-06-30	AU$8.43 Million ≈ $5.97 Million	AU$-82.44K ≈ $-58.33K	-0.010x	-109.69%
2013-06-30	AU$13.25 Million ≈ $9.38 Million	AU$1.34 Million ≈ $946.01K	0.101x	+158.23%
2012-06-30	AU$14.35 Million ≈ $10.16 Million	AU$-2.49 Million ≈ $-1.76 Million	-0.173x	+79.53%
2011-06-30	AU$6.76 Million ≈ $4.78 Million	AU$-5.72 Million ≈ $-4.05 Million	-0.847x	+9.92%
2010-06-30	AU$6.24 Million ≈ $4.41 Million	AU$-5.86 Million ≈ $-4.15 Million	-0.940x	+8.93%
2009-06-30	AU$5.53 Million ≈ $3.91 Million	AU$-5.70 Million ≈ $-4.04 Million	-1.032x	-111.67%
2008-06-30	AU$11.48 Million ≈ $8.13 Million	AU$-5.60 Million ≈ $-3.96 Million	-0.487x	+87.66%
2007-06-30	AU$1.40 Million ≈ $991.53K	AU$-5.54 Million ≈ $-3.92 Million	-3.951x	-7.34%
2006-06-30	AU$1.80 Million ≈ $1.27 Million	AU$-6.61 Million ≈ $-4.68 Million	-3.681x	-89.36%
2005-06-30	AU$3.14 Million ≈ $2.22 Million	AU$-6.09 Million ≈ $-4.31 Million	-1.944x	-302.54%
2004-06-30	AU$-1.33 Million ≈ $-937.82K	AU$-1.27 Million ≈ $-900.02K	0.960x	--

About Algorae Pharmaceuticals Ltd

AU:1AI Australia Biotechnology

Market Cap

$12.88 Million

AU$18.21 Million AUD

Market Cap Rank

#26261 Global

#1168 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$0.25